查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1606442

带状疱疹疫苗市场，按产品类型、按疫苗类型、按应用、按国家和地区 - 2024-2032 年行业分析、市场应用、市场份额和预测

Shingles Vaccine Market, By Product Type, By Vaccine Type, By Application, By Country, and By Region - Industry Analysis, Market Application, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告要点

2023年带状疱疹疫苗市场应用价值为42.5943亿美元，2024年至2032年复合年增长率为15.50%。

带状疱疹疫苗市场-市场动态

人们对带状疱疹的认识不断提高，免疫功能低下疾病的发生率不断上升，预计将推动市场需求

糖尿病、癌症、爱滋病毒/爱滋病盛行率的增加以及免疫抑制药物的使用增加了带状疱疹的易感性，增加了高风险族群接种疫苗的需求，从而推动了市场的成长。医疗机构进行的宣传活动强调带状疱疹及其严重併发症（例如带状疱疹后神经痛 (PHN)）的风险，并鼓励人们接种疫苗。疾病预防控制中心和国家卫生部门进行教育活动，促进老年人接种带状疱疹疫苗。据世界卫生组织称，到 2050 年，全球 60 岁及以上人口预计将增加一倍，目标人口规模大幅扩大。

疫苗技术的进步预计也将促进市场成长。 Shingrix（一种重组带状疱疹疫苗）的开发等创新提高了疫苗的功效和安全性，鼓励人们采用 Zostavax 等较旧的减毒活疫苗。最近，COVID-19 大流行凸显了疫苗在预防传染病方面的重要性，激发了人们对包括带状疱疹在内的其他关键疫苗的兴趣。

带状疱疹疫苗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032 年）每年将以 15.50% 左右的复合年增长率成长

根据产品类型细分，由于不良事件的有效性，Shingrix 细分市场预计将在 2023 年显示最大的市场份额。

根据疫苗类型细分，由于在病毒株中的应用更广泛，重组疫苗细分市场将成为 2023 年领先的疫苗类型细分市场。

根据应用细分，药物传输领域是 2023 年领先的应用领域，这主要是由于疫苗接种计划的采用不断增加。

从地区来看，由于顶级市场参与者的存在，北美是 2023 年的主要收入来源。

带状疱疹疫苗市场-細項分析：

全球带状疱疹疫苗市场根据产品类型、疫苗类型、应用和地区进行细分。

根据产品类型，市场分为三类：Shingrix、Zostavax 和 SKYZoster。 Shingrix 细分市场占据主导地位。由于成本效益高，SKYZoster 业务预计将以最快的速度成长。

市场依疫苗类型分为两类：重组疫苗和减毒活疫苗。重组疫苗领域占据市场主导地位。随着重组 DNA 技术的采用，这些疫苗的需求不断成长。

市场依应用分为三类：研究、药物传递和其他。药物传输领域在全球市场占据主导地位。疫苗提供持久免疫力和药物输送效率的能力预计将促进该细分市场的成长。

带状疱疹疫苗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。由于强大的医疗基础设施、高认知度以及 Shingrix 等疫苗的大量使用，北美在带状疱疹疫苗市场上占据主导地位。欧洲是第二大市场，在英国、德国和法国等国家广泛采用。欧洲疾病预防与控制中心（ECDC）加大力度协调疫苗接种政策预计将推动市场成长。由于医疗保健服务的改善、可支配收入的增加以及老年人口的增加，亚太地区正在经历快速成长。

带状疱疹疫苗市场-竞争格局：

在人们意识的提高、带状疱疹发病率上升以及政府支持的疫苗接种计划的推动下，带状疱疹疫苗市场竞争非常激烈。全球市场由几家主要参与者主导，其中葛兰素史克 (GSK) 和默克公司处于领先地位。葛兰素史克 (GSK) 的 Shingrix 疫苗拥有巨大的市场份额，这主要是由于其高效性以及越来越多的老年人推荐使用该疫苗。该公司正在投资基于 mRNA 的疫苗，其他一些重要参与者包括 SK Chemicals 和 Green Cross Corp，它们正在推出创新疫苗。

2024年4月，葛兰素史克公布了ZOSTER-049试验的结果，该试验显示Shingrix有效保护了50岁以上的人。

2023 年 2 月，辉瑞和 BioNTech 开始试验以 mRNA 为基础的带状疱疹疫苗。

目录

第一章：带状疱疹疫苗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 带状疱疹疫苗市场片段（依产品类型）
    • 带状疱疹疫苗市场片段（依疫苗类型）
    • 带状疱疹疫苗市场片段（按应用）
    • 带状疱疹疫苗市场片段（按国家/地区）
    • 带状疱疹疫苗市场片段（按地区）
  • 竞争洞察

第 3 章：带状疱疹疫苗主要市场趋势

  • 带状疱疹疫苗市场驱动因素
    • 市场驱动因素的影响分析
  • 带状疱疹疫苗市场限制
    • 市场限制影响分析
  • 带状疱疹疫苗市场机会
  • 带状疱疹疫苗市场未来趋势

第 4 章：带状疱疹疫苗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：带状疱疹疫苗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：带状疱疹疫苗市场格局

  • 2023 年带状疱疹疫苗市场占有率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：带状疱疹疫苗市场 - 按产品类型

  • 概述
    • 按产品类型分類的细分市场占有率分析
    • 欣格里克斯
    • 佐斯塔瓦克斯
    • 天空佐斯特

第 8 章：带状疱疹疫苗市场 - 按疫苗类型

  • 概述
    • 按疫苗类型分類的细分市场份额分析
    • 重组疫苗
    • 减毒活疫苗

第 9 章：带状疱疹疫苗市场 - 按应用

  • 概述
    • 按应用分類的细分市场占有率分析
    • 研究
    • 药物输送
    • 其他的

第 10 章：带状疱疹疫苗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美带状疱疹疫苗主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按产品类型）
    • 北美市场规模和预测（按疫苗类型）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲带状疱疹疫苗主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模和预测（按产品类型）
    • 欧洲市场规模和预测（按疫苗类型）
    • 欧洲市场规模和预测（按应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区带状疱疹疫苗主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（依产品类型）
    • 亚太地区市场规模与预测（依疫苗类型）
    • 亚太地区市场规模与预测（按应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲带状疱疹疫苗主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按产品类型）
    • 拉丁美洲市场规模与预测（按疫苗类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲带状疱疹疫苗主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按产品类型）
    • 中东和非洲市场规模及预测（按疫苗类型）
    • 中东和非洲市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 带状疱疹疫苗产业

  • 竞争仪表板
  • 公司简介
    • GlaxoSmithKline (GSK)
    • Merck & Co., Inc.
    • Pfizer Inc.
    • SK Chemicals
    • Green Cross Corp
    • Geneone Life Science
    • Vaccitech
    • CanSinoBIO
    • Jiangsu Recbio Technology Co., Ltd.
    • MedImmune LLC
    • AbbVie Inc.
    • Sanofi Pasteur
    • VBI Vaccines Inc.
    • Novavax Inc.
    • Bavarian Nordic
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4239

REPORT HIGHLIGHT

Shingles Vaccine Market Application was valued at USD 4,259.43 Million in 2023, expanding at a CAGR of 15.50% from 2024 to 2032.

The shingles vaccine is a medical intervention designed to reduce the risk of developing shingles (herpes zoster), a painful rash caused by the reactivation of the varicella-zoster virus, the same virus responsible for chickenpox. Shingles predominantly affects older adults or individuals with weakened immune systems. The vaccine not only decreases the likelihood of shingles but also reduces the severity and duration of symptoms.

Shingles Vaccine Market- Market Dynamics

Increasing awareness about shingles and rising incidence of immunocompromising disorders is expected to propel market demand

Increasing prevalence of diabetes, cancer, HIV/AIDS, and the use of immunosuppressive drugs increase susceptibility to shingles, boosting the need for vaccination among at-risk groups, thereby fueling market growth. Awareness campaigns by healthcare organizations emphasize the risks of shingles and its severe complications, such as postherpetic neuralgia (PHN), encouraging vaccine uptake. The CDC and national health departments run educational initiatives promoting shingles vaccination among older adults. According to WHO, the global population aged 60 and above is expected to double by 2050, significantly expanding the target demographic.

Advancement in vaccine technology is also projected to enhance market growth. Innovations such as the development of Shingrix (a recombinant zoster vaccine) have improved vaccine efficacy and safety, encouraging adoption over older live-attenuated vaccines like Zostavax. Recently, the COVID-19 pandemic highlighted the importance of vaccines in preventing infectious diseases, spurring interest in other critical vaccines, including shingles.

Shingles Vaccine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.50% over the forecast period (2024-2032)

Based on Product Type segmentation, the Shingrix segment was predicted to show maximum market share in the year 2023, owing to effectiveness in adverse events.

Based on Vaccine Type segmentation, the recombinant vaccine segment was the leading Vaccine Type segment in 2023, due to wider applications in virus strains.

Based on Application segmentation, the drug delivery segment was the leading Application segment in 2023, mainly due to the rising adoption of vaccination programs.

On the basis of region, North America was the leading revenue generator in 2023, due to the presence of top market players.

Shingles Vaccine Market- Segmentation Analysis:

Global Shingles Vaccine Market is segmented on the basis of Product Type, Vaccine Type, Application, and Region.

The market is divided into three categories based on the Product Type: Shingrix, Zostavax, and SKYZoster. The Shingrix segment dominates the market. The SKYZoster segment is estimated to grow at the fastest rate due to its high cost-effectiveness.

The market is divided into two categories based on Vaccine Type: recombinant vaccine and live attenuated vaccine. The recombinant vaccine segment dominates the market. With the adoption of recombinant DNA technology these vaccines are growing in demand.

The market is divided into three categories based on Application: research, drug delivery, and others. The drug delivery segment dominates the global market. The vaccines' ability to provide long-lasting immunity & efficiency in drug delivery is expected to boost segment growth.

Shingles Vaccine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the shingles vaccine market, driven by strong healthcare infrastructure, high awareness, and significant uptake of vaccines like Shingrix. Europe is the second-largest market, with robust adoption in countries like the UK, Germany, and France. Increased efforts by the European Centre for Disease Prevention and Control (ECDC) to harmonize vaccination policies are expected to boost market growth. Asia-Pacific is experiencing rapid growth due to improved healthcare access, rising disposable incomes, and a growing elderly population.

Shingles Vaccine Market- Competitive Landscape:

The shingles vaccine market is highly competitive, driven by increasing awareness, rising incidence of shingles, and government-backed vaccination programs. The global market is dominated by a few key players, with GlaxoSmithKline (GSK) and Merck & Co. leading the field. GSK's Shingrix vaccine has a significant market share, largely due to its high efficacy and the growing recommendation for its use among older adults. Companies are investing in mRNA-based vaccines with some other significant players include SK Chemicals and Green Cross Corp, which are introducing innovative vaccines.

In April 2024, GSK showed results from the ZOSTER-049 trial, which disclosed that Shingrix effectively protected people aged above 50.

In February 2023, Pfizer & BioNTech started trials for mRNA-based shingle vaccines.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SHINGLES VACCINE MARKET KEY PLAYERS

  • GlaxoSmithKline (GSK)
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SK Chemicals
  • Green Cross Corp
  • Geneone Life Science
  • Vaccitech
  • CanSinoBIO
  • Jiangsu Recbio Technology Co., Ltd.
  • MedImmune LLC
  • AbbVie Inc.
  • Sanofi Pasteur
  • VBI Vaccines Inc.
  • Novavax Inc.
  • Bavarian Nordic
  • Others

GLOBAL SHINGLES VACCINE MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Shingrix
  • Zostavax
  • SKYZoster

GLOBAL SHINGLES VACCINE MARKET, BY VACCINE TYPE- MARKET ANALYSIS, 2019-2032

  • Recombinant vaccine
  • Live attenuated vaccine

GLOBAL SHINGLES VACCINE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Research
  • Drug delivery
  • Others

GLOBAL SHINGLES VACCINE MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Shingles Vaccine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Shingles Vaccine Market Snippet by Product Type
    • 2.1.2. Shingles Vaccine Market Snippet by Vaccine Type
    • 2.1.3. Shingles Vaccine Market Snippet by Application
    • 2.1.4. Shingles Vaccine Market Snippet by Country
    • 2.1.5. Shingles Vaccine Market Snippet by Region
  • 2.2. Competitive Insights

3. Shingles Vaccine Key Market Trends

  • 3.1. Shingles Vaccine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Shingles Vaccine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Shingles Vaccine Market Opportunities
  • 3.4. Shingles Vaccine Market Future Trends

4. Shingles Vaccine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Shingles Vaccine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Shingles Vaccine Market Landscape

  • 6.1. Shingles Vaccine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Shingles Vaccine Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Shingrix
    • 7.1.3. Zostavax
    • 7.1.4. SKYZoster

8. Shingles Vaccine Market - By Vaccine Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Vaccine Type, 2024 & 2032 (%)
    • 8.1.2. Recombinant vaccine
    • 8.1.3. Live attenuated vaccine

9. Shingles Vaccine Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Research
    • 9.1.3. Drug delivery
    • 9.1.4. Others

10. Shingles Vaccine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Shingles Vaccine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Shingles Vaccine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Shingles Vaccine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Shingles Vaccine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Shingles Vaccine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Vaccine Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Shingles Vaccine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GlaxoSmithKline (GSK)
    • 11.2.2. Merck & Co., Inc.
    • 11.2.3. Pfizer Inc.
    • 11.2.4. SK Chemicals
    • 11.2.5. Green Cross Corp
    • 11.2.6. Geneone Life Science
    • 11.2.7. Vaccitech
    • 11.2.8. CanSinoBIO
    • 11.2.9. Jiangsu Recbio Technology Co., Ltd.
    • 11.2.10. MedImmune LLC
    • 11.2.11. AbbVie Inc.
    • 11.2.12. Sanofi Pasteur
    • 11.2.13. VBI Vaccines Inc.
    • 11.2.14. Novavax Inc.
    • 11.2.15. Bavarian Nordic
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us